Supernus Pharmaceuticals | SUPN - Loan Capital



Supernus Pharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.


Loan Capital Change Date
Abbott USD 12.93B 194M Jun/2025
ANI Pharmaceuticals USD 608.35M 3.28M Jun/2025
Aurora Cannabis CAD 36.3M 3.89M Jun/2025
Bristol-Myers Squibb USD 44.47B 1.69B Jun/2025
Canopy Growth CAD 289M 178.93M Jun/2025
Corcept Therapeutics USD 0 0 Mar/2025
Eisai JPY 99.84B 9M Jun/2025
Eli Lilly USD 34.18B 319.4M Jun/2025
Novo Nordisk 87.3B 9.01B Jun/2025
Pacira USD 378.1M 3.2M Jun/2025
Perrigo USD 3.62B 24.2M Jun/2025
Pfizer USD 57.5B 137M Jun/2025
Supernus Pharmaceuticals USD 0 0 Dec/2024
United Therapeutics USD 0 0 Mar/2025
Xeris Pharmaceuticals USD 218.63M 1.62M Jun/2025